Caribou Biosciences, INC Form 4 insider transactions
NASDAQ
Ryan Fischesser, VP of Finance and Controller at Caribou Biosciences, acquired 25,000 shares of common stock through restricted stock units.
NASDAQ
Form 4: Caribou Biosciences' Chief Medical Officer, Tina M. Albertson, Acquires 300,000 Stock Options
Tina M. Albertson, Chief Medical Officer of Caribou Biosciences, acquired options to purchase 300,000 shares of common stock on August 19, 2024.